Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  Cronos Group Inc    CRON   CA22717L1013

CRONOS GROUP INC

(CRON)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
05/14/2019 05/15/2019 05/16/2019 05/17/2019 05/21/2019 Date
20.54(c) 20.34(c) 20.5(c) 20.07(c) 20.91(c) Last
1 271 300 753 120 735 191 598 295 792 389 Volume
+6.20% -0.97% +0.79% -2.10% +4.19% Change
More quotes
Financials (CAD)
Sales 2019 56,1 M
EBIT 2019 -33,2 M
Net income 2019 1,65 M
Finance 2019 2 389 M
Yield 2019 -
Sales 2020 172 M
EBIT 2020 10,7 M
Net income 2020 49,9 M
Finance 2020 2 412 M
Yield 2020 -
P/E ratio 2019 -
P/E ratio 2020 200,70
EV / Sales2019 76,5x
EV / Sales2020 24,8x
Capitalization 6 684 M
More Financials
Company
Cronos Group Inc is a Canada-based globally diversified and vertically integrated cannabis company with a worldwide presence. The Company operates through its subsidiaries and licensed producers: Peace Naturals Project Inc, which was the non-incumbent medical cannabis license granted by Health... 
Sector
Pharmaceuticals
Calendar
06/19Shareholder meeting
More about the company
Surperformance© ratings of Cronos Group Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on CRONOS GROUP INC
05/14Cronos Group and MediPharm Labs Enter Cannabis Concentrate Supply Agreement
GL
05/09Cronos Group Inc. Announces First Quarter 2019 Results
GL
05/07Cronos Group Opens Cronos Device Labs, New Global R&D Center in Israel
GL
05/06CRONOS : Thinking about buying stock in Aurora Cannabis, Canopy Growth, Cronos G..
PR
04/09Cronos Group Inc. to Hold Conference Call on First Quarter 2019 Financial Res..
GL
03/26MARKET SNAPSHOT: Stocks Close Higher As Energy, Financial Sectors Rally
DJ
03/26Cronos Group Inc. Announces Fourth Quarter 2018 and Full Year 2018 Results
GL
03/22CEO Q&A : Altria Boss on Getting Into Weed, Taking Risks
DJ
03/08Cronos Group Inc. Closes C$2.4 Billion Strategic Growth Investment from Altri..
GL
03/04Cronos Group Inc. Exits Investment in Whistler Medical Marijuana Corporation
GL
More news
Analyst Recommendations on CRONOS GROUP INC
More recommendations
Sector news : Alternative Medicine
02:48aSANOFI : French Deal Spree Fueled By Easy Money
DJ
05/21UPDATE : N.Y. Jury Delivers $25 Million Judgment Against Johnson & Johnson -- Bl..
DJ
05/21JOHNSON & JOHNSON : Correction to Johnson & Johnson Jury Story
DJ
05/21JOHNSON & JOHNSON : N.Y. Jury Delivers $25 Million Judgment Against Johnson & Jo..
DJ
05/21BAYER : hires law firm to probe Monsanto data collection
RE
More sector news : Alternative Medicine
Chart CRONOS GROUP INC
Duration : Period :
Cronos Group Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CRONOS GROUP INC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 11
Average target price 19,5  CAD
Spread / Average Target -2,6%
EPS Revisions
Managers
NameTitle
Michael Gorenstein Chairman, President & Chief Executive Officer
David Hsu Chief Operating Officer
William Hilson Chief Financial Officer
Alan Friedman Independent Director
Jason M. Adler Director
Sector and Competitors
1st jan.Capitalization (M$)
CRONOS GROUP INC45.41%4 981
CANOPY GROWTH CORP64.00%15 383
AURORA CANNABIS INC72.71%8 841
BEIJING TONGRENTANG CO., LTD.7.60%5 879
DONG-E-E-JIAO CO LTD--.--%3 856
HUTCHISON CHINA MEDITECH LIMITED20.57%3 539